Composta da scienziati di fama internazionale, ha il compito di garantire che i fondi Telethon vengano assegnati ai progetti più promettenti presentati ai bandi competitivi e di monitorare il lavoro degli Istituti.
L’eccellenza al centro di ogni valutazione: è il principio da cui parte la nostra commissione medico scientifica per scegliere i progetti meritevoli dei fondi. Senza però dimenticare che gli studi finanziati da Telethon devono avere rilevanza per i pazienti e contribuire ad avvicinare alla cura. Tutti i membri della commissione, che provengono da ogni parte del mondo, restano in carica per quattro anni e tra loro vi sono pochi italiani, per minimizzare i conflitti di interesse.
2632
progetti e attività finanziati
1612
ricercatori finanziati
I membri della Commissione
- Yvan Arsenijevic, Hôpital Ophtalmique Jules Gonin (Lausanne, Switzerland)
- Victoria P. Belancio, Tulane University (New Orleans, LA - USA)
- Robert M. Brosh, National Institute on Aging (Baltimore, MD – USA)
- Patrick Brundin, Center for Neurodegenerative Science, Van Andel Institute (Grand Rapids, MI – USA)
- Judith Campisi, Buck Institute for Research on Aging (Novato, CA – USA)
- Jeffrey S. Chamberlain, University of Washington (Seattle, WA – USA)
- Jeffrey Dilworth, Ottawa Hospital Research Institute (Ottawa, Canada) – Vice Chairperson
- Daniel Garry, University of Minnesota (Minneapolis, MN - USA)
- Alfred L. George, Feinberg School of Medicine, Northwestern University (Chicago, IL – USA)
- Gregory G. Germino, National Institutes of Health, Kidney Disease Branch/National Institute of Diabetes and Digestive and Kidney Disease (Bethesda, MD – USA)
- Markus Glatzel, University Medical Center Hamburg-Eppendorf, UKE (Hamburg, Germany)
- Åsa Gustafsson, UC San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences (San Diego, La Jolla, CA - USA)
- Simon Heales, University College London – UCL (UK)
- Lynn Jorde, University of Utah (Salt Lake City, UT – USA)
- Nicholas Katsanis, Northwestern University Feinberg School of Medicine (Chicago, IL – USA)
- Albert R. La Spada, Duke University School of Medicine (Durham, NC - USA)
- Holger Lerche, University of Tübingen (Tübingen, Germany)
- Fransiska Malfait, Center for Medical Genetics, Ghent Universit (Ghent, Belgium)
- Punam Malik, University of Cincinnati (Cincinnati, OH – USA)
- Jeffrey Molkentin, University of Cincinnati (Cincinnati, OH – USA)
- Geert Mortier, Antwerp University Hospital (Antwerp, Belgium)
- Michael P. Murphy, University of Cambridge, (Cambridge, UK)
- Nael Nadif Kasri, Radboud University Nijmegen (Nijmegen, The Netherlands)
- Kanneboyina Nagaraju, Department of Pharmaceutical Sciences, Binghamton University (Binghamton, NY - USA)
- Bradley B. Olwin, University of Colorado (Boulder, CO - USA)
- Harry Orr, University of Minnesota (Minneapolis, MN – USA)
- Francesc Palau, Institute of Rare and Genetic Diseases (Barcelona, Spain)
- Massimo Pandolfo, Erasme Hospital (Brussels, Belgium)
- Ambra Pozzi, Vanderbilt University (Nashville, TN - USA)
- Thomas A. Rando, Stanford University School of Medicine (Stanford, CA – USA)
- Laura Ranum, University of Florida (Gainesville, FL – USA)
- Paul Robbins, University of Minnesota Medical School (Minneapolis, MN –USA).
- Michael Talkowski, Broad Institute of MIT and Harvard (Cambridge, MA - USA)
- Naomi Taylor, Institute of Molecular Genetics of Montpellier (Montpellier, France) and National Human Genome Research Institute, NIH (Bethesda, MD – USA) Chairperson
- Raul Urrutia, Medical College of Wisconsin (Milwaukee, WI - USA)
- Charles Venditti, National Human Genome Research Institute, NIH (Bethesda, MD – USA)
- Ora A. Weisz, University of Pittsburgh School of Medicine(Pittsburgh, PA – USA)
